The Food and Drug Administration awarded the drug’s sponsor, biotech company Revolution Medicines, a new and unconventional ...

The latest of those is a bid valued at up to $10 billion for U.S. obesity-drug developer Metsera, up from a previous $9 billion offer it originally made, as it tries to usurp an already agreed-on deal ...

Developers of biosimilars will no longer be required to conduct clinical trials to prove effectiveness for FDA approval.

The firm's data and services revenues grew 26 percent to $81.3 million, while genomics revenues more than doubled to $252.9 million.

This article was reviewed by Darragh O’Carroll, MD. GLP-1 for Weight Loss: Everything You Need to Know Key takeaways: GLP-1s ...

The Food and Drug Administration has announced the recall of thousands of makeup remover wipes because they may be ...

Americans are being asked across the country to check their refrigerators for a pre-cooked pasta meal which might contain ...

New research from the UW School of Medicine shows telehealth services for medication abortion increased after the Dobbs ...

Sales and production of the sauces made by First and Last Bakery have been suspended to ensure compliance with regulations, ...

Wegovy-maker Novo Nordisk presented new data on Wednesday showing its experimental weight-loss pill improved blood sugar ...

Hilliard, the HHS spokesperson, told SFGATE on Tuesday that, “Secretary [Robert F.] Kennedy [Jr.] expects the highest ethical ...

A green light would have made Vyglxia the first and only FDA-approved treatment for spinocerebellar ataxia, a life-threatening neurodegenerative disease characterized by progressive loss of voluntary ...